{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T20:10:06Z","timestamp":1756671006955,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Psychotropic medicines are commonly prescribed as when required (PRN) prescriptions for inpatients for anxiety, insomnia or as part of a strategy to de-escalate situations that may lead to violence and aggression. While these medicines can provide benefit, safeguards need to be in place to ensure they are regularly reviewed and not overused.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim and methodology<\/jats:title>\n                  <jats:p>To (1) establish baseline practice around the clinical review of psychotropic PRN medicines for inpatients and (2) improve clinical practice around the clinical review of PRN medicines from baseline and the end of the improvement programme.<\/jats:p>\n                  <jats:p>Centrally coordinated, locally driven, improvement programme taking place over a 5-month period between February and June 2024. The programme employed a learning system approach to enable doctors to test change ideas and share areas of good practice as they sought to understand the problem, test different approaches and focus on holding the gains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>21 wards participated and at an aggregate level achieved both aims with the recording of clinical reviews in the notes increasing from 89% to 90% and the quality of what was recorded in the notes increasing from 51% to 72%. There were signs of increased adjustments to psychotropic PRN medicines during the programme and in some wards decreased rates of psychotropic PRN administration to patients. However, while overall levels of psychotropic PRN medicine administration benchmarked lower than those reported in other studies, there were significant differences in clinical reviews, prescription and administration rates between a group of wards that fully engaged and partially engaged in the improvement programme.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Employing a learning system approach helped create a context suitable for improvement and led to improvements in the review of psychotropic PRN medicines. Exploring the variation between wards in fully engaged and partially engaged groups of wards could be a next step for the Trust.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjoq-2024-003094","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:10:23Z","timestamp":1740481823000},"page":"e003094","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Improving the quality and reliability of clinical reviews of psychotropic PRN medicines in a large English mental health Trust"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4594-9565","authenticated-orcid":false,"given":"James","family":"Innes","sequence":"first","affiliation":[{"name":"Norfolk and Suffolk NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uju","family":"Ugochukwu","sequence":"additional","affiliation":[{"name":"Norfolk and Suffolk NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Trenholm","sequence":"additional","affiliation":[{"name":"Norfolk and Suffolk NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Boswell","sequence":"additional","affiliation":[{"name":"Norfolk and Suffolk NHS Foundation Trust, Norwich, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025083112421952000_14.1.e003094.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2006.12.005"},{"key":"2025083112421952000_14.1.e003094.2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/inm.12306","article-title":"Nurses\u2019 attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings","volume":"27","author":"Barr","year":"2018","journal-title":"Int J Ment Health Nurs"},{"key":"2025083112421952000_14.1.e003094.3","article-title":"'As required' medication regimens for seriously mentally ill people in hospital","volume":"2015","author":"Douglas-Hall","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083112421952000_14.1.e003094.4","unstructured":"National Institute for Health and Care Excellence . Violence and aggression: short-term management in mental health, health and community settings. 2015. Available: https:\/\/www.nice.org.uk\/guidance\/ng10\/resources\/violence-and-aggression-shortterm-management-in-mental-health-health-and-community-settings-pdf-1837264712389"},{"key":"2025083112421952000_14.1.e003094.5","unstructured":"Care Quality Commission . When required medicines in adult social care. 2022. Available: https:\/\/www.cqc.org.uk\/guidance-providers\/adult-social-care\/when-required-medicines-adult-social-care"},{"key":"2025083112421952000_14.1.e003094.6","unstructured":"Royal College of Psychiatrists . Standards for Acute Inpatient Service Working Age Adults, 2022. Available: https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/ccqi\/ccqi-resources\/ccqi-core-standards-in-2022.pdf?sfvrsn=ae828418_8"},{"key":"2025083112421952000_14.1.e003094.7","unstructured":"Care Quality Commission . Appropriate use of psychotropic medicines in adult social care. 2022. Available: https:\/\/www.cqc.org.uk\/guidance-providers\/adult-social-care\/appropriate-use-psychotropic-medicines-adult-social-care [Accessed 30 Jul 2024]."},{"key":"2025083112421952000_14.1.e003094.8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14999013.2020.1774686","article-title":"PRN Medication Events in a Forensic Psychiatric Hospital: A Document Analysis of the Prevalence and Reasons","volume":"19","author":"Hipp","year":"2020","journal-title":"Int J Forensic Ment Health"},{"key":"2025083112421952000_14.1.e003094.9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/01612840.2018.1543739","article-title":"The Administration of Pro re nata Medication by Mental Health Nurses: A Thematic Analysis","volume":"40","author":"Jimu","year":"2019","journal-title":"Issues Ment Health Nurs"},{"key":"2025083112421952000_14.1.e003094.10","doi-asserted-by":"crossref","first-page":"759998","DOI":"10.3389\/fphar.2022.759998","article-title":"Practical Considerations of PRN Medicines Management: An Integrative Systematic Review","volume":"13","author":"Mardani","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025083112421952000_14.1.e003094.11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/pharmacy9040174","article-title":"Ethical Tenets of PRN Medicines Management in Healthcare Settings: A Clinical Perspective","volume":"9","author":"Vaismoradi","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"2025083112421952000_14.1.e003094.12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7748\/mhp.2021.e1589","article-title":"Promoting alternatives to PRN medicines in secure inpatient mental health services","volume":"25","author":"McDougall","year":"2022","journal-title":"Mental Health Practice"},{"key":"2025083112421952000_14.1.e003094.13","doi-asserted-by":"crossref","first-page":"bmjoq","DOI":"10.1136\/bmjoq-2020-001277","article-title":"Improving documentation of prescriptions for as-required medications in hospital inpatients","volume":"10","author":"Ross","year":"2021","journal-title":"BMJ Open Qual"},{"key":"2025083112421952000_14.1.e003094.14","unstructured":"Provost LP , Murray SK . The healthcare data guide. learning from data for improvement. josey bass, 2011:978\u20130."},{"key":"2025083112421952000_14.1.e003094.15","unstructured":"Lloyd R . Quality Health Care: A Guide to Developing and Using Indicators. 2nd edn. Jones & Bartlett Learning, 2019:978\u20131."},{"key":"2025083112421952000_14.1.e003094.16","unstructured":"Institute for Healthcare Improvement . The breakthrough series. ihi\u2019s collaborative model for achieving breakthrough improvement. 2003. Available: https:\/\/www.ihi.org [Accessed 2 Sep 2024]."},{"key":"2025083112421952000_14.1.e003094.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2008.01.004"},{"key":"2025083112421952000_14.1.e003094.18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/inm.12265","article-title":"Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital","volume":"26","author":"Martin","year":"2017","journal-title":"Int J Ment Health Nurs"},{"key":"2025083112421952000_14.1.e003094.19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1078390321994668","article-title":"Characterization of Psychotropic PRN Medications in a Canadian Psychiatric Intensive Care Unit","volume":"29","author":"Casol","year":"2023","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"2025083112421952000_14.1.e003094.20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.042895"},{"key":"2025083112421952000_14.1.e003094.21","unstructured":"Royal College of Psychiatrists . The risks and benefits of high-dose antipsychotic medication. 2014."},{"key":"2025083112421952000_14.1.e003094.22","doi-asserted-by":"publisher","DOI":"10.1111\/jpm.12129"},{"key":"2025083112421952000_14.1.e003094.23","unstructured":"Dixon-Woods M . Perspectives on context: the problem of context in quality improvement. The Health Foundation; 2014. Available: https:\/\/www.health.org.uk\/sites\/default\/files\/PerspectivesOnContextDixonWoodsTheProblemOfContextInQualityImprovement.pdf"},{"key":"2025083112421952000_14.1.e003094.24","unstructured":"Bate P , Robert G , Fulop N , et al . Perspectives on context. a selection of essays considering the role of context in successful quality improvement. The Health Foundation; 2014. Available: https:\/\/www.health.org.uk\/sites\/default\/files\/PerspectivesOnContext_fullversion.pdf"},{"key":"2025083112421952000_14.1.e003094.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076648","article-title":"What are the features of high-performing quality improvement collaboratives? A qualitative case study of a state-wide collaboratives programme","volume":"13","author":"McGowan","year":"2023","journal-title":"BMJ Open"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2024-003094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:42:32Z","timestamp":1756669352000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2024-003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjoq-2024-003094"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2024-003094","relation":{},"ISSN":["2399-6641"],"issn-type":[{"type":"electronic","value":"2399-6641"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}